Matrix and Bioreactors for Human Lung Regeneration
Matrix and Bioreactors for Human Lung Regeneration
批准号:
8224021
负责人:
LAURA E NIKLASON
金额:
$69.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2016-12-31
关键词:
AddressAdhesionsAnimalsArchitectureAutomobile DrivingBehaviorBiomedical EngineeringBioreactorsBlocking AntibodiesBlood VesselsCell physiologyCellsCessation of lifeChronicChronic lung diseaseConfocal MicroscopyCuesCystic FibrosisCytoskeletonDataDevelopmentDiseaseElementsEnvironmental air flowEpithelialEvaluationEventExperimental ModelsExtracellular MatrixFeasibility StudiesGasesGenesGoalsGrowthHumanImageImaging DeviceImmunohistochemistryInfectionKnock-outKnowledgeLaboratoriesLungLung TransplantationLung diseasesMaintenanceMeasuresMechanical ventilationMechanicsMediatingMesenchymalMethodsMissionModalityMorbidity - disease rateMorphogenesisNatural regenerationPatientsPeptidesPerfusionPhenotypePhysiologicalPreparationPrincipal InvestigatorProcessProliferatingProteinsProteomicsPulmonary EmphysemaPulmonary FibrosisPulmonary alveolar structureResearchRespiratory FailureRespiratory physiologyRodentSliceStagingStructureStructure of parenchyma of lungSurvival RateSymptomsTechnologyTestingTherapeutic InterventionTimeTissuesTransmission Electron MicroscopyUnited StatesWorkallograft rejectioncellular imagingimaging modalityinnovationlung developmentlung imaginglung repairmembermortalitynovelrepairedresearch studyscaffoldsuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Advanced or end-stage lung diseases, such as pulmonary fibrosis, emphysema, and cystic fibrosis, are a major cause of morbidity and mortality in the United States. Although lung transplantation is a viable alternative for some patients, the 5-year survival rate of approximately 50% (primarily due to chronic allograft rejection and/or infection) limits this modality as a long-term therapy. Moreover, the scarcity of donated lungs and the short graft viability times post-explant are major limitations. Thus, there i a desperate need both for understanding pathophysiologic mechanisms in chronic lung diseases as well as for devising innovative methods to repair or bioengineer functional lungs. Thus, this proposal will test the hypothesis that the lung extracellular matrix (ECM) drives the proper localization, differentiation, and function of lung cells and is the key contributor to norml lung repair and regeneration. With a long-term goal of regenerating a functional human lung, we propose to critically examine the constitutive makeup of the decellularized lung ECM and to develop new tools for assessing lung matrix structure and function. Further, we propose to develop a human lung bioreactor that allows for optimal preparation of decellularized human lung matrices while maintaining physiologic ventilation and perfusion. Among the questions to be addressed are: 1) what are the key components of lung ECM that drive cellular behavior and function? 2) How can we better assess the barrier function and structure of lung ECM? 3) Can we develop a bioreactor that will allow a human lung to be decellularized and subsequently recellularized while undergoing mechanical ventilation and vascular perfusion? Work in this U01 application will be instrumental for the success of the Lung Regeneration Consortium, because we will generate a basic and comprehensive understanding of the lung matrix that is used as a substrate for lung growth. We will also develop tools and bioreactors that will enable other Consortium members to utilize and leverage our findings. RELEVANCE: The relevance of this research is to begin studying the feasibility of regenerating a functional human lung in the laboratory. Studies proposed will comprehensively define the protein makeup of the normal human lung, will devise novel methods of imaging the cellular repopulation of human lung tissues, and will develop a novel bioreactor in which human lungs can be regenerated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biologically Selective Drug-Eluting Stent
-
批准号:10183318
-
项目类别:
-
资助金额:$68.59万
-
财政年份:2019
-
负责人:LAURA E NIKLASON
-
依托单位:
Engineered Tracheal Replacements
-
批准号:9376650
-
项目类别:
-
资助金额:$64.62万
-
财政年份:2017
-
负责人:LAURA E NIKLASON
-
依托单位:
Hyaluronan Coatings for Engineered Vessels
-
批准号:9230431
-
项目类别:
-
资助金额:$61.91万
-
财政年份:2016
-
负责人:LAURA E NIKLASON
-
依托单位:
Hyaluronan Coatings for Engineered Vessels
-
批准号:9038008
-
项目类别:
-
资助金额:$61.96万
-
财政年份:2016
-
负责人:LAURA E NIKLASON
-
依托单位:
Matrix and Bioreactors for Human Lung Regeneration
-
批准号:8403690
-
项目类别:
-
资助金额:$65.09万
-
财政年份:2012
-
负责人:LAURA E NIKLASON
-
依托单位:
Matrix and Bioreactors for Human Lung Regeneration
-
批准号:8979704
-
项目类别:
-
资助金额:$62.29万
-
财政年份:2012
-
负责人:LAURA E NIKLASON
-
依托单位:
Matrix and Bioreactors for Human Lung Regeneration
-
批准号:8601879
-
项目类别:
-
资助金额:$64.69万
-
财政年份:2012
-
负责人:LAURA E NIKLASON
-
依托单位:
Lung Tissue Engineering
-
批准号:8011997
-
项目类别:
-
资助金额:$63.06万
-
财政年份:2010
-
负责人:LAURA E NIKLASON
-
依托单位:
Lung Tissue Engineering
-
批准号:7765764
-
项目类别:
-
资助金额:$63.54万
-
财政年份:2010
-
负责人:LAURA E NIKLASON
-
依托单位:
Lung Tissue Engineering
-
批准号:8206739
-
项目类别:
-
资助金额:$62.05万
-
财政年份:2010
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:8281687
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:9067378
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:7560494
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:8092736
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:8500360
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:7880869
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:8877561
-
项目类别:
-
资助金额:$19.3万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Research Training in Anesthesia
-
批准号:9297309
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2009
-
负责人:LAURA E NIKLASON
-
依托单位:
Biological Vascular Grafts
-
批准号:8237548
-
项目类别:
-
资助金额:$60.18万
-
财政年份:2006
-
负责人:LAURA E NIKLASON
-
依托单位:
Biological Vascular Grafts
-
批准号:8582558
-
项目类别:
-
资助金额:$57.05万
-
财政年份:2006
-
负责人:LAURA E NIKLASON
-
依托单位:
海外基金